Skip to content

Rifampicin and pyrazinamide treatment for latent TB in HIV patients does not carry high risk of liver injury, but editorial still urges caution

A rare human genetic make-up gives the best chance against HIV

Acetyl-l-carnitine can improve peripheral neuropathy, study shows

UK government to finance vaccine drive by bond sales: model for global AIDS treatment?

Early liver enzyme elevations wane with prolonged HAART treatment in women with HCV

News from the Fifteenth International AIDS Conference

Second major study shows rise in drug resistance is not increasing AIDS or death risk

Oral sex between men a ‘small but real risk’ for HIV transmission, survey shows

US government will not override Abbott's ritonavir patent